Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Clinical Investigation to Assess the Diagnostic Precision of the AI Tool Dermalyzer to Identify Malignant Melanomas in Subjects Seeking Primary Care for Melanoma-suspected Cutaneous Lesions

NCT05172232 is registered in ClinicalTrials.gov with Linkoeping University as lead sponsor.

NCT NCT05172232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05172232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Clinical Investigation to Assess the Diagnostic Precision of the AI Tool Dermalyzer to Identify Malignant Melanomas in Subjects Seeking Primary Care for Melanoma-suspected Cutaneous Lesions
Lead sponsor
Linkoeping University
Phase
Observational
Overall status
Completed
Start date
May 2, 2022
Completion date
January 23, 2023
Enrollment
231 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma